Disease | heart disease |
Symptom | |fibrillation |
Sentences | 71 |
PubMedID- 20668657 | However, this judgment was seriously questioned by both (1) a study, in which erp was found to be a clinically relevant ecg signature, and possibly a marker of scd, in the evaluation of unexplained syncope or idiopathic ventricular fibrillation in patients without structural heart disease . |
PubMedID- 23126050 | The patient was already known to have liver cirrhosis of ethylic etiology, cardiac decompensation caused by hypertensive heart disease with permanent atrial fibrillation, chronic obstructive pulmonary disease, diabetes mellitus type 2, and cholelithiasis. |
PubMedID- 22845816 | Atrial fibrillation in the absence of organic heart disease or risk factors (lone atrial fibrillation) appears to carry significantly lower risk especially in younger patients (approximately 1.3% per year). |
PubMedID- 23110977 | revealed reduced approximate entropy preceding spontaneous onset of paroxysmal atrial fibrillation in patients without structural heart disease (0.89 ± 0.27 versus 1.02 ± 0.30). |
PubMedID- 25692832 | Catheter ablation of focus triggering ventricular fibrillation in patients with structural heart disease. |
PubMedID- 26519209 | Inherited structural heart diseases with potential atrial fibrillation occurrence. |
PubMedID- 23631185 | Atrial fibrillation concomitant with valvular heart disease. |
PubMedID- 24072689 | In ‘lone’ atrial fibrillation (absence of heart disease) the stroke risk is only 0.5 % per year 2, whereas in atrial fibrillation associated with rheumatic valvular heart disease, such as mitral valve stenosis, it is very high. |
PubMedID- 23075140 | Valvular heart disease is a cause of atrial fibrillation (af) . |
PubMedID- 25216788 | Light and electron microscopic features of surgically excised left atrial appendage in rheumatic heart disease patients with atrial fibrillation and sinus rhythm. |
PubMedID- 21311690 | The loss of short-term fractal correlation property that we found in copd subjects is related to the occurrence of several adverse clinical events such as heart failure23,25 and acute myocardial infarction.30 in addition, reduction of alpha-1 was observed before spontaneous onset of atrial fibrillation in patients without structural heart disease27 associated with vulnerability to ventricular tachycardia23,30 and ventricular fibrillation.31 exponent values lower than 0.85 were observed in patients with cardiovascular disease associated with increased mortality rate.28–30 these values are close to those found in our study (alpha-1 = 0.899) in copd patients. |
PubMedID- 25151145 | Angiotensin ii activates signal transducers and activators of transcription 3 via rac1 in the atrial tissue in permanent atrial fibrillation patients with rheumatic heart disease. |
PubMedID- 25796343 | We investigated the relationship between transient receptor potential channel subfamily m6 (trpm6) and atrial fibrosis in rheumatic heart disease patients with atrial fibrillation (af). |
PubMedID- 21911268 | The increase in sympathetic nerve density in the atrium facilitates atrial fibrillation in patients with rheumatic heart disease. |
PubMedID- 21672267 | The investigation was a cohort medical record study of patients who were resuscitated from out-of-hospital ventricular fibrillation arrest due to heart disease and discharged alive from the hospital in seattle and king county from november 1, 2003 through december 31, 2005. king county including seattle has an area of approximately 2000 square miles, a population of 1.75 million, and includes urban, suburban, and rural areas. |
PubMedID- 22113757 | Background: acute alcohol consumption can cause atrial fibrillation in patients with, and without, heart disease. |
PubMedID- 23121003 | Prolonged atrial effective refractory periods in atrial fibrillation patients associated with structural heart disease or sinus node dysfunction compared with lone atrial fibrillation. |
PubMedID- 22830646 | A slow hrr post-exercise, which is governed at least in part by the autonomic nervous system (ans) via parasympathetic reactivation, may increase the susceptibility to ventricular fibrillation in patients with ischemic heart disease 8. |
PubMedID- 25742550 | The midterm results of radiofrequency ablation and vagal denervation in the surgical treatment of long-standing atrial fibrillation associated with rheumatic heart disease. |
PubMedID- 20657030 | Background: early repolarization, indicated on the standard 12-lead ecg, has recently been associated with idiopathic ventricular fibrillation in patients without structural heart disease. |
PubMedID- 21287469 | New procedure for treatment of atrial fibrillation in patients with valvular heart disease. |
PubMedID- 20413814 | The purpose of the study was to estimate efficiency of atorvastatin in complex treatment with antiarhythmic drugs on the background of ischemic heart disease in patients with paroxysmal atrial fibrillation (af). |
PubMedID- 22676979 | Conclusions: concomitant bipolar radiofrequency ablation is an effective and safe technique for treating atrial fibrillation in patients with rheumatic heart disease undergoing valve replacement, with promising follow-up results. |
PubMedID- 22084633 | Decreased complexity in heart rate behavior measured by approximate entropy has been found to precede spontaneous episodes of atrial fibrillation in patients without structural heart disease (vikman et al., 1999) and in patients after coronary artery bypass surgery (hogue et al., 1998). |
PubMedID- 23280242 | Introduction: atrial tachyarrhythmias, particularly atrial flutter and fibrillation, are commonly associated with congenital heart disease and are a major cause of morbidity and mortality. |
PubMedID- 20937979 | Electropathological substrate of longstanding persistent atrial fibrillation in patients with structural heart disease: epicardial breakthrough. |
PubMedID- 20519808 | We recruited 1,759 subjects without atrial fibrillation or history of ischemic heart disease aged 38-95 years (mean age +/- standard deviation 64.5 +/- 10.9 years, 56.1% women, mean bmi 22.8 +/- 3.1 kg/m(2)) from the participants in the suita study between august 2002 and december 2003. |
PubMedID- 22291468 | This agent can be considered as a first-line therapy for atrial fibrillation in patients with structural heart disease who have an ejection fraction >35% and no recent decompensated heart failure. |
PubMedID- 23631186 | Management of atrial fibrillation comorbid with coronary heart disease. |
PubMedID- 21804774 | Atrial fibrillation in the absence of organic heart disease or risk factors (lone atrial fibrillation) appears to carry significantly lower risk especially in younger patients (approximately 1.3% per year). |
PubMedID- 22108512 | Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease. |
PubMedID- 22136173 | Introduction: premature ventricular contractions (pvcs) arising from the right ventricular outflow tract (rvot) can trigger polymorphic ventricular tachycardia (pvt) or ventricular fibrillation (vf) in patients with no structural heart disease. |
PubMedID- 21816308 | Background: early repolarization has been implicated in a syndrome of polymorphic ventricular tachycardia and fibrillation in patients without organic heart disease. |
PubMedID- 24755126 | Objective: to compare the therapeutic warfarin and aspirin efficacies for treatments of atrial fibrillation (af) complicated with stable coronary heart disease particularly in older chinese patients. |
PubMedID- 23778479 | Prolongation in pwd is related to an increased risk of atrial fibrillation development in patients with various heart diseases (10,11) and sleeping disorders, such as obstructive sleep apnea (12). |
PubMedID- 24487524 | Thirty-three patients (2.5%) suffered an adverse event, 272 (21%) experienced a left atrial tachycardia, and 4 patients died (1 haemorrhagic stroke, 1 ventricular fibrillation in a patient with ischaemic heart disease, 1 cancer, and 1 of unknown cause). |
PubMedID- 23683253 | Introduction: an oral loading dose of propafenone 600 mg is used in our center as in other places around the world for conversion of recent-onset atrial fibrillation (af) in patients without structural heart disease. |
PubMedID- 21584749 | However, in chronic atrial fibrillation patients without structural heart disease, b-type natriuretic peptide levels did not differ between those with and without heart failure symptoms. |
PubMedID- 26056191 | Thus, single oral doses of 600 mg propafenone appear also suitable for cardioversion of paroxysmal atrial fibrillation in patients with structural heart disease since beta-blockers are explicitly indicated in the treatment of both coronary artery disease and heart failure. |
PubMedID- 24273583 | Thus, it is advised to measure serum thyrotropin in all elderly patients with systolic hypertension, widened blood pressure, recent-onset angina, atrial fibrillation and any exacerbation of ischemic heart disease, and treat . |
PubMedID- 23015920 | Task force 7 from the 36th bethesda conference recommends that athletes with atrial fibrillation and no evidence of structural heart disease can compete without restrictions if they are able to maintain a normal dynamic range of their heart rate with exercise. |
PubMedID- 24088003 | The use of implantable devices for long-term monitoring of cardiac rhythm after surgical treatment of atrial fibrillation in patients with ischemic heart disease. |
PubMedID- 24508178 | Background: early repolarization (er) is associated with increased risk of sudden cardiac death and ventricular fibrillation (vf) in patients with/without structural heart disease. |
PubMedID- 23397903 | Early repolarization pattern (erp) is associated with ventricular fibrillation in patients without structural heart diseases. |
PubMedID- 25457137 | Biphasic transthoracic cardioversion of atrial fibrillation in dogs with naturally occurring heart disease has been described in veterinary medicine and has been shown to be highly successful. |
PubMedID- 25766663 | Early efficacy analysis of biatrial ablation versus left and simplified right atrial ablation for atrial fibrillation treatment in patients with rheumatic heart disease. |
PubMedID- 21219558 | Atrial fibrillation is commonly associated with structural heart disease and is a major cause of significant cardiovascular morbidity and mortality. |
PubMedID- 26261514 | Therefore, we hypothesized that synd4 shedding was also involved in the inflammatory response in atrial fibrillation patients with valvular heart disease. |
PubMedID- 22699292 | Subsequent models included additional adjustment for education, annual household income, health insurance, geographic region, urban/rural residence, systolic blood pressure, antihypertensive medication use, smoking status, alcohol consumption, bmi, atrial fibrillation, lvh, and history of coronary heart disease. |
PubMedID- 22547769 | Aims: the aim of this study was to determine whether altered expression and distribution of calcium- and integrin-binding protein-1 (cib1) is involved in the pathogenesis of different types of patients with atrial fibrillation (af) associated with valvular heart disease (vhd). |
Page: 1 2